Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Tangible Net Worth Ratio
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Tangible Net Worth Ratio of 91.5% as of June 2025. This metric is calculated by deducting intangible assets (CN¥117.17 Million) from net assets (CN¥1.38 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shandong Keyuan Pharmaceutical Co. Ltd. net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Keyuan Pharmaceutical Co. Ltd. A Tangible Net Worth Ratio (2021–2024)
This chart shows how Shandong Keyuan Pharmaceutical Co. Ltd. A's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 91.5%, reflecting net assets of CN¥1.38 Billion with intangible assets of CN¥117.17 Million CNY. Also explore net asset growth rate of Shandong Keyuan Pharmaceutical Co. Ltd. to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shandong Keyuan Pharmaceutical Co. Ltd. (301281) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 92.0% | CN¥1.36 Billion | CN¥108.98 Million | CN¥1.55 Billion | ▼ -4.6 pp |
| 2023 | 96.5% | CN¥1.33 Billion | CN¥46.02 Million | CN¥1.47 Billion | ▲ +6.0 pp |
| 2022 | 90.6% | CN¥519.73 Million | CN¥49.08 Million | CN¥651.79 Million | ▲ +2.6 pp |
| 2021 | 88.0% | CN¥430.98 Million | CN¥51.76 Million | CN¥559.51 Million | — |